Wael Saber, M.D., M.S.
Assistant Professor of Medicine
Dr. Wael Saber joined the faculty of Medical College of Wisconsin (MCW) in 2009 as an Assistant Professor of Medicine in the Division of Hematology and Oncology. He is also an Assistant Scientific Director in the Center for International Blood and Marrow Transplant Research (CIBMTR) at the Medical College of Wisconsin, an internationally recognized research organization that focuses on outcomes related to Hematopoietic Stem Cell Transplantation (HCT).
Dr. Saber attended medical school at Ain Shams University in Egypt, and completed his internship and residency at the Cleveland Clinic Foundation. He completed an NIH T-32 research fellowship in Hematology at the University of Wisconsin in Madison. He holds a master’s degree in population health sciences from the University of Wisconsin.
Dr. Saber is an attending physician in the MCW adult HCT unit, with clinical interests in hematologic malignancies. His research interests are focused on outcomes related to HCT.
Advani AS, Jin T, Ramsingh G, Tiu R, Saber W, Theil K, Sobecks R, Sekeres M, Copelan E, Sungren S, Tripp B, Kalaycio M. Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia. Leuk Lymphoma 49(8):1560-6, 2008.
Advani AS, Rodriguez C, Jin T, Jawda RA, Saber W, Baz R, Kalaycio M, Sobecks R, Sekeres M, Tripp B, Hsi E. Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML. Leuk Res 32(6):913-8, 2008.